Virtu Financial LLC Provention Bio, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$3.65 - $7.3 $64,878 - $129,757	17,775 New	17,775 $71,000
Q2 2021 Sep 17, 2021	SELL	$6.71 - $11.04 $131,898 - $217,013	-19,657 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$10.12 - $19.45 $198,928 - $382,328	19,657 New	19,657 $206,000
Q3 2020 Dec 11, 2020	SELL	$10.34 - $15.2 $582,545 - $856,352	-56,339 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.81 - $17.0 $229,731 - $500,055	29,415 Added 109.25%	56,339 $795,000
Q4 2019 Feb 04, 2020	BUY	$5.84 - $14.9 $157,236 - $401,167	26,924 New	26,924 $401,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.